Clinical Laboratory Services Market Research Report by Provider, Speciality, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

The Global Clinical Laboratory Services Market size was estimated at USD 202.01 billion in 2021 and expected to reach USD 219.87 billion in 2022, and is projected to grow at a CAGR 9.01% to reach USD 339.10 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Clinical Laboratory Services to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Provider, the market was studied across Hospital-Based Laboratories, Independent & Reference Laboratories, and Nursing & Physician Office-Based Laboratories.

Based on Speciality, the market was studied across Clinical Chemistry Testing, Cytology Testing, Drugs of Abuse Testing, Genetic Testing, Hematology Testing, Immunology Testing, and Microbiology Testing. The Clinical Chemistry Testing is further studied across Endocrinology Chemistry Testing, Routine Chemistry Testing, Specialized Chemistry Testing, and Therapeutic Drug Monitoring Testing. The Immunology Testing is further studied across Coagulation Testing, Routine Hematology Testing, and Specialized Hematology Testing. The Microbiology Testing is further studied across Infectious Disease Testing and Transplant Diagnostic Testing.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Clinical Laboratory Services market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Laboratory Services Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Laboratory Services Market, including Abbott Laboratories, ACM Medical Laboratory, Inc., Adicon Clinical Laboratories, Inc., Amedes Holding GmbH, Arup Laboratories Inc, Cerba HealthCare S.A.S. By PAI Partners, Charles River Laboratories, Clinical Reference Laboratory, Inc., DaVita Inc., Eurofins Scientific SE, Fullerton Healthcare Corporation Limited, Laboratory Corporation of America Holdings, LifeLabs Inc., Neogenomics Laboratories, Inc., Opko Health, Inc, Quest Diagnostics Inc., SGS SA, Siemens Healthcare GmbH, Sonic Healthcare Ltd., Spectra Laboratories Inc., SYNLAB International GmbH, Thermo Fisher Scientific, Unilabs SA, and Viapath Group LLP.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Clinical Laboratory Services Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Clinical Laboratory Services Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Clinical Laboratory Services Market?
4. What is the competitive strategic window for opportunities in the Global Clinical Laboratory Services Market?
5. What are the technology trends and regulatory frameworks in the Global Clinical Laboratory Services Market?
6. What is the market share of the leading vendors in the Global Clinical Laboratory Services Market?
7. What modes and strategic moves are considered suitable for entering the Global Clinical Laboratory Services Market?

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of diseases and infections coupled with surging elderly populace
5.1.1.2. Increasing investments from government and private sector for innovative infrastructure in clinical labs
5.1.1.3. Potential and imminent need for early detection and diagnosis of diseases
5.1.2. Restraints
5.1.2.1. Steady shift from laboratory testing to home-based or POC testing
5.1.3. Opportunities
5.1.3.1. Increasing implementation of digital pathology platforms
5.1.3.2. Demand for stand-alone laboratories performing accurate testing and use of automated medical devices
5.1.4. Challenges
5.1.4.1. Dearth of test kits, PPE and sample collection materials coupled with shortage of skilled clinicians
5.2. Cumulative Impact of COVID-19

6. Clinical Laboratory Services Market, by Provider
6.1. Introduction
6.2. Hospital-Based Laboratories
6.3. Independent & Reference Laboratories
6.4. Nursing & Physician Office-Based Laboratories

7. Clinical Laboratory Services Market, by Speciality
7.1. Introduction
7.2. Clinical Chemistry Testing
7.3.1. Endocrinology Chemistry Testing
7.3.2. Routine Chemistry Testing
7.3.3. Specialized Chemistry Testing
7.3.4. Therapeutic Drug Monitoring Testing
7.3. Cytology Testing
7.4. Drugs of Abuse Testing
7.5. Genetic Testing
7.6. Hematology Testing
7.7. Immunology Testing
7.8.1. Coagulation Testing
7.8.2. Routine Hematology Testing
7.8.3. Specialized Hematology Testing
7.8. Microbiology Testing
7.9.1. Infectious Disease Testing
7.9.2. Transplant Diagnostic Testing

8. Americas Clinical Laboratory Services Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Clinical Laboratory Services Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Clinical Laboratory Services Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbott Laboratories
12.1.1. Business Overview
12.1.2. Key Executives
12.1.3. Product & Services
12.2. ACM Medical Laboratory, Inc.
12.2.1. Business Overview
12.2.2. Key Executives
12.2.3. Product & Services
12.3. Adicon Clinical Laboratories, Inc.
12.3.1. Business Overview
12.3.2. Key Executives
12.3.3. Product & Services
12.4. Amedes Holding GmbH
12.4.1. Business Overview
12.4.2. Key Executives
12.4.3. Product & Services
12.5. Arup Laboratories Inc
12.5.1. Business Overview
12.5.2. Key Executives
12.5.3. Product & Services
12.6. Cerba HealthCare S.A.S. By PAI Partners
12.6.1. Business Overview
12.6.2. Key Executives
12.6.3. Product & Services
12.7. Charles River Laboratories
12.7.1. Business Overview
12.7.2. Key Executives
12.7.3. Product & Services
12.8. Clinical Reference Laboratory, Inc.
12.8.1. Business Overview
12.8.2. Key Executives
12.8.3. Product & Services
12.9. DaVita Inc.
12.9.1. Business Overview
12.9.2. Key Executives
12.9.3. Product & Services
12.10. Eurofins Scientific SE
12.10.1. Business Overview
12.10.2. Key Executives
12.10.3. Product & Services
12.11. Fullerton Healthcare Corporation Limited
12.11.1. Business Overview
12.11.2. Key Executives
12.11.3. Product & Services
12.12. Laboratory Corporation of America Holdings
12.12.1. Business Overview
12.12.2. Key Executives
12.12.3. Product & Services
12.13. LifeLabs Inc.
12.13.1. Business Overview
12.13.2. Key Executives
12.13.3. Product & Services
12.14. Neogenomics Laboratories, Inc.
12.14.1. Business Overview
12.14.2. Key Executives
12.14.3. Product & Services
12.15. Opko Health, Inc
12.15.1. Business Overview
12.15.2. Key Executives
12.15.3. Product & Services
12.16. Quest Diagnostics Inc.
12.16.1. Business Overview
12.16.2. Key Executives
12.16.3. Product & Services
12.17. SGS SA
12.17.1. Business Overview
12.17.2. Key Executives
12.17.3. Product & Services
12.18. Siemens Healthcare GmbH
12.18.1. Business Overview
12.18.2. Key Executives
12.18.3. Product & Services
12.19. Sonic Healthcare Ltd.
12.19.1. Business Overview
12.19.2. Key Executives
12.19.3. Product & Services
12.20. Spectra Laboratories Inc.
12.20.1. Business Overview
12.20.2. Key Executives
12.20.3. Product & Services
12.21. SYNLAB International GmbH
12.21.1. Business Overview
12.21.2. Key Executives
12.21.3. Product & Services
12.22. Thermo Fisher Scientific
12.22.1. Business Overview
12.22.2. Key Executives
12.22.3. Product & Services
12.23. Unilabs SA
12.23.1. Business Overview
12.23.2. Key Executives
12.23.3. Product & Services
12.24. Viapath Group LLP
12.24.1. Business Overview
12.24.2. Key Executives
12.24.3. Product & Services

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing